- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06464900
Effects of a Health Intervention on Fear of Hypoglycemia
July 7, 2024 updated by: Zhao Yueqi, Yangzhou University
Effects of a Health Education Intervention Based on the Behaviour Change Wheel on Fear of Hypoglycemia in Patients With Type 2 Diabetes Mellitus: a Randomized Controlled Study
To examine the effects of a health Education Intervention based on the Behaviour Change Wheel (BCW) theory on fear of hypoglycemia and relevant outcomes of type 2 diabetic patients.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
In this study, eligible participants were randomized in a 1:1 ratio into an intervention group (health education based on BCW theory given on top of regular diabetes health education) and a control group (regular diabetes health education), with a 4-week intervention period and a 8-week follow-up period, for a total of 12 weeks.
Study Type
Interventional
Enrollment (Estimated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ma Hongxin, Master
- Phone Number: +86 87974902
- Email: 007032@yzu.edu.cn
Study Locations
-
-
Jiangsu
-
Yangzhou, Jiangsu, China, 225000
- Yangzhou University
-
Contact:
- Hongxin Ma, Master
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Comply with the 2020 Chinese guidelines for the prevention and treatment of type 2 diabetes mellitus;
- Age ≥18 years;
- Duration of diabetes mellitus ≥1 year;
- FoH according to the elevated item endorsement criterion (E I criterion): ≥3 points on any item of the Hypoglycemic Fear-Worry Scale (HFS-WS);
- Patients who have the ability to listen, read, write, walk, and cooperate to complete the study;
- Patients who have a smart phone, and can skillfully use WeChat or telephone to communicate;
- Voluntarily participate in this study and sign the informed consent form.
Exclusion Criteria:
- Patients with comorbid acute complications or other serious diseases or disorders of consciousness, such as diabetic hypertonic state, tumors, coma, etc;
- Patients with comorbid psychiatric diseases or taking psychotropic drugs;
- Patients who have recently or are participating in other studies on similar topics.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Routine Care
Implementation of routine diabetes health education.
|
Provide patients with regular medication guidance, dietary guidance, exercise guidance and knowledge about diabetes mellitus and hypoglycaemia; test and record blood glucose regularly every day; answer patients' clinical questions and provide psychological support in a timely manner.
|
|
Experimental: Based on BCW Theory of Health Education
A FoH intervention program based on BCW theory was implemented on top of the routine care.
|
BCW theory was applied to analyse behaviour and develop interventions in terms of capability, motivation and opportunity.
Capability: Intensive daily management of diabetes through intervention functions (education, training, persuasion, modelling) to change attitudes and habits, understand the negative consequences of fear of hypoglycaemia, improve hypoglycaemia awareness and self-regulation skills.
Opportunity: Through the intervention function (education, training, realization) to improve the awareness of hypoglycemia awareness, timely detection of hypoglycemia.
In the event of a hypoglycaemic event patients know how to deal with it.
Motivation: Through intervention functions (environmental reconstruction, realisation) that take full account of external factors and their own opportunities.
Glucose management through microsoft platforms, on-site teaching and coaching by specialist nurses to create opportunities for patients who can change excessive/avoidant behaviours.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hypoglycemia fear survey
Time Frame: Baseline, 4 and 12 weeks post-intervention
|
Fear of hypoglycemia (FoH) was assessed using the Hypoglycemic Fear Survey Scale (HFS), which consists of two subscales, the Hypoglycemic Fear Survey- Behavioral Scale (HFS-BS) and the Hypoglycemic Fear Survey-Worry Scale (HFS-WS).
(1) The HFS-BS scale has 19 entries, using a 5-point Likert scale, with scores ranging from 1 ~ 5 in descending order, and a total score of 15 ~ 95, with higher scores indicating more obvious hypoglycemic fearful behaviors in patients.
(2) HFS-WS has 13 entries, which were scored using a 5-point Likert scale, with scores ranging from 0 to 4 from low to high, and a total score of 0 ~ 52.
The higher the score, the higher the degree of fear of hypoglycemia in patients.
The two subscale scores were added together, and the higher the total score, the more severe the fear of hypoglycemia.
|
Baseline, 4 and 12 weeks post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gold Rating
Time Frame: Baseline, 4 and 12 weeks post-intervention
|
The Gold Score, first proposed by Professor Gold of the United Kingdom in 1994, is currently the most commonly used method of assessing Impaired Awareness of Hypoglycemia (IAH), which reflects the patient's awareness of hypoglycemia side by side.
The method consists of a single question, "Do you know when your hypoglycemia began?"
Answers are given on a 7-point Likert scale ranging from "1" (always aware) to "7" (never aware), with a score of 1-3 being considered normal self-awareness of hypoglycemia, and a score of ≥4 indicating the presence of IAH.
|
Baseline, 4 and 12 weeks post-intervention
|
|
The Patients Assessment Chronic Illness Care( PACIC)
Time Frame: Baseline, 4 and 12 weeks post-intervention
|
Used to assess the quality of care provided by healthcare organizations in the U.S. chronic disease management model.
The scale is completed by patients to report the extent to which they have received care in the past 6 months consistent with the chronic disease management model and can be used to reflect the level of medical support provided to patients by chronic disease management organizations such as hospitals.The PACIC scale is divided into 5 dimensions and 20 questions, each of which is based on the use of a 5-dimensional model of care.
7~11), problem solving/coherence (entries 12~15), and follow-up/collaboration (entries 16~20), and each entry is rated on a 5-point Likert scale, with scores ranging from 1~5 from the lowest to the highest, and with scores closer to 5, the higher the evaluation of chronic disease management, and the more support the patient receives from healthcare professionals.
|
Baseline, 4 and 12 weeks post-intervention
|
|
The self-management attitude scale for diabetes patients
Time Frame: Baseline, 4 and 12 weeks post-intervention
|
The subscale has 5 entries to evaluate patients' attitudes toward diabetes health education, diet control, exercise, medication compliance, and blood glucose monitoring.
A Likert 5-point scale was used, assigning values of 1.0, 0.8, 0.6, 0.4, 0.2 in descending order, and the total mean scores of the 5 entries (range 0.2-1.0)
represented the self-management attitude scores.
A total mean score of <3.0 indicates a poor self-management attitude, 3.0 to 4.25 indicates a moderate self-management attitude, and >4.25 indicates a good self-management attitude.
|
Baseline, 4 and 12 weeks post-intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Zhao Yueqi, Master, Yangzhou University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
July 1, 2024
Primary Completion (Estimated)
January 1, 2025
Study Completion (Estimated)
January 1, 2025
Study Registration Dates
First Submitted
June 13, 2024
First Submitted That Met QC Criteria
June 13, 2024
First Posted (Actual)
June 18, 2024
Study Record Updates
Last Update Posted (Actual)
July 9, 2024
Last Update Submitted That Met QC Criteria
July 7, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- YZUHL20230040
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Health Education
-
Basque Health ServiceUnknownHealth Promotion | Health Behavior | Health Education | Patient Education | Counseling | Behavior TherapySpain
-
University Medical Center GoettingenNot yet recruitingNursing Education | Health Education | Oral Health Care | Oral Health Education
-
Liverpool John Moores UniversityUniversity of Central Lancashire; Queen's University, Belfast; Newcastle University and other collaboratorsCompletedMedical Education | Health Education | Educational AssessmentUnited Kingdom
-
Universidad Nacional de la MatanzaRecruiting
-
Rio de Janeiro State UniversityCompleted
-
University of ArizonaNational Institute of Environmental Health Sciences (NIEHS)RecruitingEducation, HealthUnited States
-
Sheba Medical CenterWithdrawnEducation, HealthIsrael
-
Istanbul Bilgi UniversityCompleted
-
Hepatopancreatobiliary Surgery Institute of Gansu...CompletedHealth EducationChina
Clinical Trials on Routine Care
-
Hoag Memorial Hospital PresbyterianInstitute for Systems Biology; ArivaleCompletedCognitive Impairment | Alzheimer DiseaseUnited States
-
Yonsei UniversityCompletedPancreaticobiliary CancerKorea, Republic of
-
Beijing Children's HospitalCompletedA Study on the Effect of Animation-based Nurse-Patient Interaction Model on Postoperative Pain in Children With Congenital Heart DiseaseChina
-
Ministry of Science and Technology, TaiwanCompletedCognitive Change | Education
-
Peking University First HospitalBeijing Jishuitan HospitalWithdrawnPostoperative Delirium | Orthopedic Surgery | Treatment | Acupuncture | Older PatientsChina
-
Hacettepe UniversityNuh Naci Yazgan UniversityEnrolling by invitationPhysical Therapy | Women Health | Gynecologic SurgeriesTurkey
-
NHS FifeRoyal College of Emergency MedicineNot yet recruitingPsychological Distress | Mental Health | Substance Use (Drugs, Alcohol)United Kingdom
-
Robert ColebundersPatrick KototoNot yet recruiting
-
University Hospital Center of MartiniqueRecruiting
-
University Hospital Center of MartiniqueNot yet recruiting